2-piperidone has been researched along with zstk474 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barollo, S; Bertazza, L; Casal Ide, E; Cavedon, E; Censi, S; Iacobone, M; Manso, J; Mian, C; Pezzani, R; Sensi, F; Vianello, F; Watutantrige-Fernando, S | 1 |
1 other study(ies) available for 2-piperidone and zstk474
| Article | Year |
|---|---|
EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer.
Topics: Aged; Anilides; Antineoplastic Agents; Benzylidene Compounds; Carcinoma, Neuroendocrine; Cell Proliferation; Drug Synergism; Female; Humans; Male; Middle Aged; Piperidones; Pyridines; Thyroid Neoplasms; Triazines; Tumor Cells, Cultured | 2018 |